Investors & Media

Apr 09, 2008 International Stem Cell Corporation Announces Collaboration with the University of Cambridge to Study Parthenogenetic Stem Cells

Apr 03, 2008 International Stem Cell Corporation Signs Letter of Intent with BioTime, Inc., and Embryome Sciences to Provide Unique Human Stem Cell Lines for Research Use

Mar 31, 2008 International Stem Cell Corporation Announces Manufacturing and Supply Agreement With ATCC

Feb 28, 2008 International Stem Cell Corporation's Human Parthenogenetic Stem Cells to be used in Germany in the Development of Treatments for Neural Disease

Jan 29, 2008 International Stem Cell Corporation to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference February 19, 2008

Jan 22, 2008 International Stem Cell Corporation Chairman Adds CEO Role

Jan 18, 2008 INTERNATIONAL STEM CELL CORPORATION CHAIRMAN KENNETH ALDRICH TO BE INTERVIEWED ON WALLST.NET

Jan 14, 2008 International Stem Cell Corporation to Provide Corneal Epithelial Cells Differentiated from Its Parthenogenetic Stem Cells for Use in Photorefractive Keratectomy (PRK) FDA Clinical Trials

Dec 18, 2007 Human Embryonic Stem Cell Lines Created That Avoid Immune Rejection in Large Segments of the Population

Nov 25, 2007 International Stem Cell Corporation CEO Issues Statement on De-Differentiation Research and Parthenogenesis

26 27 28 29 30 31 32 33

<< < > >>